6.37  +0.03 (+0.47%)
High: 6.51 Low: 6.32
Open: 6.40 Market Cap: 762,304,270
Company News · Profile · Market Summary
Marketwatch · Disclaimer: All data is delayed by 15 minutes
11/23/2009 4:57:00 PM - PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend ... 11/12/2009 4:56:00 PM - PDL BioPharma Announces Special Dividend Paymen...
www.pdl.com/ www.pdl.com/
PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share. 12/01/09. PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of ...
www.pdl.com/index.cfm?navId=22 www.pdl.com/index.cfm?navId=22
PDL's humanization technology licensing portfolio is among the most successful and profitable in the history of the U.S. biotechnology industry. ...
www.pdlbiopharma.com/index.cfm?navId=195 www.pdlbiopharma.com/index.cfm?navId=195
PDL BioPharma (PDLI) was a biotech research and development company until recently when it spun-off the research and development portion of the business, leaving behind six employees and seven patents to protect.
seekingalpha.com/article/129492-pdl-biopharma-past-pres... seekingalpha.com/article/129492-pdl-biopharma-past-present-and-future
When measured by its dividend, PDL BioPharma, (PDLI), stands out as one of the best stocks to buy in the biotech field. In fact, it's one of only four dividend paying stocks in this sub-sector. ... PDL BioPharma: High Dividend Biotech Stock 5 comments...
seekingalpha.com/article/156454-pdl-biopharma-high-divi... seekingalpha.com/article/156454-pdl-biopharma-high-dividend-biotech-stock
See the company profile for PDL BioPharma, Inc. (PDLI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their compensation. ... PDL BioPharma, Inc., a biopharmaceutical company, engages in the discovery and development of antibodies...
finance.yahoo.com/q/pr?s=pdli finance.yahoo.com/q/pr?s=pdli
CEDAR KNOLLS, NJ and REDWOOD CITY, CA--(Marketwire - February 4, 2008) - EKR Therapeutics, Inc. ... and PDL BioPharma, Inc. ... PDL BioPharma, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. For more information,
www.marketwire.com/press-release/Pdl-Biopharma-NASDAQ-P... www.marketwire.com/press-release/Pdl-Biopharma-NASDAQ-PDLI-817332.html
View the PDL BioPharma company profile on LinkedIn. See recent hires and promotions, competitors and how you’re connected to PDL BioPharma. ... PDL BioPharma, Inc., a biopharmaceutical company, engages in the discovery and development of antibodies for oncology and immunologic diseases worldwide.
www.linkedin.com/companies/pdl-biopharma www.linkedin.com/companies/pdl-biopharma
PDL BioPharma, Inc. (PDLI) Reschedules Third Quarter 2009 Financial Results Conference Call for 8:30 a.m. ET on October 28, 2009 10/28/2009 10:48:18 AM    More... ... PDL BioPharma, Inc. (PDLI) to Present at Oppenheimer & Co. 20th Annual Healthcare Conference on November 4, 2009 10/28/2009 10:03:48 AM    More...
www.biospace.com/company_profile.aspx?CompanyId=1001176
Definitions